A viral immunotherapy for cancer has become the first of its kind to be approved by the European Medicines Agency for use in adults with advanced melanoma.

ICR Scientists have developed a new imaging test that could enable doctors to identify more dangerous tumours before they spread around the body – and tailor treatment accordingly.

New survival mechanism could be a target for future cancer drugs